Werewolf Therapeutics, Inc.·4

May 4, 4:31 PM ET

Trost Timothy W. 4

4 · Werewolf Therapeutics, Inc. · Filed May 4, 2021

Insider Transaction Report

Form 4
Period: 2021-02-12
Trost Timothy W.
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-12+247,812247,812 total
    Exercise: $5.98Exp: 2031-02-11Common Stock (247,812 underlying)
  • Award

    Stock Option (right to buy)

    2021-04-30+54,75654,756 total
    Exercise: $16.00Exp: 2031-04-29Common Stock (54,756 underlying)
Footnotes (2)
  • [F1]The option was granted on February 12, 2021 with a Vesting Commencement Date of February 8, 2021. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through February 8, 2025.
  • [F2]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION